1) 骨粗鬆症の予防と治療ガイドライン作成委員会(編).骨粗鬆症の予防と治療ガイドライン2015年版.
2) Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures:a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15(4):721-39.
3) 椎体骨折評価委員会(編).椎体骨折診療ガイド.東京:ライフサイエンス出版;2014.
4) Maier SP, Smith JS, Schwab FJ, et al. Revision surgery after 3-column osteotomy in 335 patients with adult spinal deformity:intercenter variability and risk factors. Spine (Phila Pa 1976) 2014;39(11):881-5.
5) Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8(9):1137-48.
6) Yoshimura N, Kinoshita H, Danjoh S, et al. Prevalence of vertebral fractures in a rural Japanese population. J Epidemiology 1995;5(4):171-5.
7) 八尋俊輔,角田雅也,西本浩司・他.当科における大腿骨近位部骨折患者に対する骨粗鬆症治療の現状.骨折2017;39(3):652-5.
8) Migliore A, Broccoli S, Massafra U, et al. Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis. Eur Rev Med Pharamacol Sci 2013;17(5):658-67.
9) 日本腎臓学会(編).CKD診療ガイド2012.東京:東京医学社;2012.
10) Ebata S, Takahashi J, Hasegawa T, et al. Role of weekly teriparatide administration in osseous union enhancement within six months after posterior or transforaminal lumbar interbody fusion for osteoporosis-associated lumbar degenerative disorders:a multicenter, prospective randomized study. J Bone Joint Surgery 2017;99(5):365-72.
11) Seki S, Hirano N, Kawaguchi Y, et al. Teriparatide versus low-dose bisphosphonates before and after surgery for adult spinal deformity in female Japanese patients with osteoporosis. Eur Spine J 2017;26(8):2121-7.
12) Ohtori S, Inoue G, Orita S, et al. Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine (Phila Pa 1976) 2013;38(8):487-92.